How This CRISPR Biotech Could Make Investors Rich Post author:Sam Post published:December 26, 2017 Post category:BioPharma A look at a biotech company that represents a solid trend in the industry. Source: BioSpace You Might Also Like Pfizer Quietly Takes Passive Stake in This Boston Pharma October 18, 2017 Bay Area's Carmot Lands $240M+ R&D Tie-Up With Biotech Giant Amgen December 5, 2017 Acorda Plunges After the FDA Rejects Marketing App for Parkinson's Disease Drug August 28, 2017
